May 11, 2023
Partnership aims to integrate ScaleReady’s CGT manufacturing workflow with Cellular Origins’ robotic technology Initially focussed on automation of ScaleReady’s G-Rex platform Cambridge, UK, and St. Paul, MN, USA: Cellular Origins, a TTP Company focused on enabling scalable, cost-effective and efficient manufacture of cell and gene therapies (CGTs), has today announced a collaborative partnership with ScaleReady, [...]
May 11, 2023
All Employees to Become Owners in the Company NEW YORK – KKR, a leading global investment firm, today announced the signing of a definitive agreement under which investment funds managed by KKR will acquire Industrial Physics (or the “Company”), a leading manufacturer of testing and measurement instruments, from Union Park Capital (“UPC”). KKR plans to [...]
May 10, 2023
MINNEAPOLIS -- Bio-Techne (NASDAQ: TECH), a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities today announced the launch of two new RNAscope™ in situ Hybridization Probes Kappa and Lambda as analyte specific reagents (ASRs) for the detection of immunoglobulin kappa and lambda light chains mRNA in B-cells. Detection of [...]
May 10, 2023
Investment will advance smart farming technology to empower growers with real-time portable lab data and to support the carbon credit industry with scientifically accurate measurements MONTREAL -- ChrysaLabs, a leading innovator at the forefront of soil science, announced today a 15 million Canadian dollar ($11 million) financing round, including investments from Leaps by Bayer, TELUS Ventures and BDC Capital. Existing investors Ecofuel, Emmertech, [...]
Ribbon Biolabs Appoints Jodi Barrientos as Chief Business Officer
May 10, 2023
VIENNA -- Ribbon Biolabs, the DNA synthesis company, today announced the appointment of Jodi Barrientos as Chief Business Officer. With over 17 years of experience in industry-leading life science and diagnostics companies, Jodi Barrientos brings deep knowledge and expertise in commercial strategy, operations, and enterprise development focused on key synthetic biology and genomics markets. In [...]
VERDER GROUP ACQUIRES FORMULACTION
May 10, 2023
The Verder Group today announces the acquisition of Formulaction S.A. of France. As part of the group’s Scientific Division Formulaction will be integrated into Microtrac MRB, a leading manufacturer of Particle Characterization Systems. Haan – The Verder Group today announces the acquisition of Formulaction S.A. of France. As part of the group’s Scientific Division Formulaction will [...]
May 10, 2023
Transaction to Enable Continued Acquisitions and Growth for USCO SpA and DWK Life Sciences NEW YORK -- Please replace the release with the following corrected version due to multiple revisions. The updated release reads: ONE EQUITY PARTNERS CLOSES $1 BILLION CONTINUATION FUND CO-LED BY ALPINVEST PARTNERS AND HARBOURVEST PARTNERS Transaction to Enable Continued Acquisitions and [...]
ibidi Product News: ibidi Releases Bovine Version of Collagen Type I for Cell Culture Applications
May 10, 2023
Munich, Germany—ibidi is now offering two versions of Collagen Type I with different origins: the new bovine and the already popular rat tail. With this addition, scientists have the option to choose a collagen that best matches their preferences and experimental needs. The ibidi Collagens Type I can be used in a wide range of [...]
ONI appoints Grace DeSantis as VP Biology & Chemistry to lead Bioware function
May 10, 2023
We’re excited to announce that Grace DeSantis has joined ONI as VP Biology & Chemistry. Grace will be driving our Bioware function, and leading our Applications Development and Chemistry teams between Oxford and San Diego. Grace joins us from her executive R&D role at Illumina, where she oversaw R&D, clinical product innovation and product development for 9 [...]
Launching Revvity: A Scientific Solutions Company Powering Innovation from Discovery to Cure
May 10, 2023
Transformation aimed at revolutionizing next generation scientific breakthroughs that solve the world’s greatest health challenges Trusted partner to pharma, government and diagnostics customers with complete, end-to-end solutions To begin trading as RVTY under new name on May 16th (formerly NYSE: PKI) WALTHAM, Mass. – Revvity, Inc. officially launches today as a science-based solutions company that leverages [...]

